Influence of methylenetetrahydrofolate reductase genotype, exercise and other risk factors on endothelial function in healthy individuals

Clinical Science

Volumn 102, Issue 1, 2002, Pages 45-50

  Pullin, Catherine H ^a   Wilson, John F ^a   Ashfield Watt, Pauline A L ^a   Clark, Zoë E ^a   Whiting, Jenny M ^a   Lewis, Malcolm J ^a   McDowell, Ian F W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Genetics; Primary prevention; Risk factors; Vascular endothelium

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIOXIDANT; CHOLESTEROL; COD LIVER OIL; HOMOCYSTEINE; VITAMIN;

AEROBIC METABOLISM; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENVIRONMENTAL FACTOR; ENZYME ASSAY; EXERCISE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MULTIPLE REGRESSION; NORMAL HUMAN; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NORMAL DISTRIBUTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PHOTOPLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0036181008     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010161     Document Type: Article

References (35)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
2. Plasma homocysteine and coronary heart disease: Systematic review of punished epidemiological studies
3. Putative mechanisms for vascular damage by homocysteine
4. Impaired homocysteine metabolism and atherthrombotic disease
5. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
6. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Endothelium-dependent flow-mediated vasodilatation in coronary and brachial arteries in suspected coronary artery disease
9. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
10. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
11. Benefits of physical activity in the prevention of cardiovascular disease
12. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
13. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease
14. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension
15. Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant) using heteroduplex technology
16. 'Optimisation' of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults irrespective of methylenetetrahydrofolate reductase (C677T) genotype
17. Endothelial control of arterial distensibility is impaired in chronic heart failure
18. Flow-mediated dilatation following wrist and upper arm occlusion in humans: The contribution of nitric oxide
19. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilatation in healthy men
20. Regular aerobic exercise augments endothelial-dependent relaxation in normotensive as well as hypertensive subjects: Role of endothelium-derived nitric oxide
21. Effect of exercise on coronary endothelial function in patients with coronary artery disease
22. Exercise training enhances endothelial function in young men
23. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction
24. Cardiovascular disease risk and hormone replacement therapy (HRT): A review based on randomised, controlled studies in postmenopausal women
25. Hormone replacement therapy is associated with improved physiology in healthy post-menopausal women
26. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
27. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
28. Hyperhomocysteinemia increases risk of death, especially in diabetes: 5-year follow-up of the Hoorn Study
29. Vitamin C improves endothelial-dependent vasodilatation in resistance vessels of humans with hypercholesterolemia
30. Vitamin C improves endothelial-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus
31. Dietary supplementation with marine omega-3 fatty acids improves systemic large artery endothelial function in subjects with hypercholesterolemia
32. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress
33. Cyclic strain increases endothelial nitric oxide synthase activity
34. Up-regulation of nitric oxide synthase by estradiol in human endothelial cells
35. Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats